ITOS iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA.
$34.65 -2.12 (-5.77%)
As of 03/05/2021 15:59:53 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
07/24/2020
35,044,758
174,135
$1,213,950,417
0.00%
SEC Edgar Online
10-Q
10-K
46565G104
US46565G1040
BMWXFT4
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
07/24/2020
35,044,758
174,135
$1,213,950,417
0.00%
SEC Edgar Online
10-Q
10-K
46565G104
US46565G1040
BMWXFT4
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
3.62
0.00
-8.49%
0.00%
3.62
0.00
-8.49%
0.00%